With age, GSH levels decrease by up to 50% compared to young subjects, contributing to increased oxidative stress and chronic low-grade inflammation (inflammaging). In the anti-ageing field, GSH IV acts on three main levels: direct neutralisation of free radicals and protection of dermal collagen, modulation of inflammation through NF-B inhibition, and reduction of melanogenesis through tyrosinase inhibition with clinically observable effects on skin tone and luminosity. The most robust clinical evidence concerns neuroprotection (improvement of motor symptoms in Parkinson's disease) and protection from chemotherapy-induced neuropathy
I market compounded tirzepatide to patients, but I am not the compounder
Given the prevalence of unregulated peptide products, this presents substantial compliance risks to military personnel
Usually, it is four to five years before something is FDA-approved
In humans, alpha-lipoic acid is naturally produced in the mitochondria but is also found in several food sources, which we'll get to in a moment
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
